This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hill-Rom Holdings' Management Presents At Bank Of America Merrill Lynch 2012 Health Care Conference (Transcript)

Hill-Rom Holdings, Inc. (HRC)

Bank of America Merrill Lynch 2012 Health Care Conference

May 16, 2012, 1:40 p.m. ET


John Greisch – President and CEO

Mark Guinan – CFO


Lennox Ketner – BofA Merrill Lynch



Lennox Ketner – Bank of America, Merrill Lynch

Next up we have Hill-Rom. Presenting for the company we have the CEO John Greisch, and with him we also have the CFO, Mark Guinan, and the head of Investor Relations, Andy Reith. John is going to go ahead and speak for 10 minutes or so, give a basic overview of the company, and then we’ll dive into Q&A. Thanks.

John Greisch

Thanks, good morning everybody. Let me just make a few comments before we jump into Q&A here, to start with the normal caveat on any forward-looking information that we may be discussing today. I’d like to refer everybody back to our SEC filings.

Just a quick overview for those of you not that familiar with the Hill-Rom story. We’re about a billion six, billion seven revenue medical device company, serving the full range of the care continuum, from home care, extended care and acute care hospitals. Our core business is in the area of patient handling, patient mobility, so beds, surfaces, patient lifts, and environmental systems, what we refer to there are architectural products and other products to go into the either acute care setting or extended care setting, really to deal with patient handling, patient mobility. We’ve also got a respiratory care franchise and a surgical care franchise. Those, together with our core franchise, is really focused on enhancing outcomes, improving costs for our customers and helping them address their needs, which I’ll touch on here in a few minutes. I think many of you have heard us talk about also the increasing demand for connectivity, getting information off of our products into EMR systems or nurse call systems, which is obviously also a key focus for us.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.05 -0.61%
FB $117.85 -0.18%
GOOG $697.18 0.21%
TSLA $213.89 -3.90%
YHOO $36.98 2.70%


Chart of I:DJI
DOW 17,699.06 +47.80 0.27%
S&P 500 2,060.08 +8.96 0.44%
NASDAQ 4,743.5680 +17.9290 0.38%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs